To determine whether altered central and/or peripheral gamma-aminobutyric acid (GABA)ergic mechanisms acting in GABA A receptors contribute to the abnormal ventilatory response to acute and sustained hypoxia in obese Zucker rats. METHODS: In all, 10 lean and 10 obese Zucker rats were studied at 12 weeks of age. Ventilation ( . V E ), tidal volume (V T ), and breathing frequency (f) during room air breathing and in response to sustained (30 min) hypoxic (10% O 2 ) challenges were measured on three separate occasions by the barometric method following the randomized blinded administration of equal volumes of DMSO (vehicle), bicuculline methiodide (B M , 1 mg/kg, peripheral GABA A receptor antagonist), or bicuculline hydrochloride (B HCl , 1 mg/kg, peripheral and central GABA A receptor antagonist). RESULTS: Administration of B M and B HCl in lean animals had no effect on ventilation either during room air breathing or 30 min of sustained exposure to hypoxia. Similarly, B M failed to alter ventilation in obese rats. In contrast, B HCl significantly (Po0.05) increased
Introduction
Morbid obesity is often associated with alveolar hypoventilation resulting from excess respiratory demands and insufficient respiratory output. Abnormal respiratory control in some forms of obesity may lead to a decrease in ventilatory compensation and, in time, to the development of chronic alveolar hypoventilation (hypoxemia and hypercapnia), a condition commonly referred to as obesity hypoventilation syndrome (OHS). 1, 2 The obese Zucker rat, a model of morbid obesity, presents many of the same respiratory deficits as noted in morbidly obese humans, 3, 4 including abnormal respiratory control mechanisms. [5] [6] [7] The underlying mechanisms responsible for these abnormal ventilatory responses in obesity are still unclear, but are related to altered neuromodulation, which have been reported in obese Zucker rats from our previous studies. [5] [6] [7] [8] [9] [10] Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the mammalian central nervous system (CNS) and acts at approximately 25-40% of the synapses within the CNS. 11 GABA A receptors have been shown to be involved in the generation and the modulation of respiration. 12, 13 During hypoxic challenges, brain GABA levels increase and exert an inhibitory modulation during the sustained hypoxic ventilatory response, 14, 15 whereas the GABAergic mechanism during acute hypoxia is much unclear. The obese Zucker rat shows accelerated synthesis of GABA in the brain stem 16 and possesses altered brain GABAergic mechanisms that contribute to their overeating. 16, 17 Our previous investigations have revealed important links between GABAergic mechanisms and impaired breathing control in obesity. 5 Increased GABAergic activity appears to generally depress ventilation in obese Zucker rats. 5 However, central GABA and intracarotid GABA challenges have been reported in a contrary manner, ventilatory inhibition and tidal volume elevation, respectively. 11, 14, 15, 18 Therefore, the clarification of peripheral vs central GABAergic modulation is needed. The ventilatory response to acute and sustained hypoxia is biphasic; the neural mechanisms responsible for the early ventilatory response to hypoxia are postulated to be quite different from the neural mechanisms responsible for the late response. 19 Our previous study shows that endogenous GABA modulates ventilation during room air breathing and the ventilatory response at 20 min hypoxic exposure in obese Zucker rats. 5 However, no further evidence indicates that GABAergic modulation during acute and sustained hypoxic ventilatory response in obesity is mediated via either a central or peripheral mechanism. The purpose of this study, therefore, was to investigate whether GABA modulates the ventilatory response to acute (5 min) and sustained (10-30 min) hypoxia in morbidly obese Zucker rats. A second goal of the study was to distinguish the possible effects attributed to GABA A receptors located within the CNS from those mediated by GABA A receptors located within peripheral structures. We hypothesized that endogenous GABA acting specifically on central but not on peripheral GABA A receptors modulates ventilation during room air breathing and the ventilatory response to acute and sustained hypoxia in obese, but not lean, Zucker rats. A parallel study design was used, with lean, agematched Zucker rats serving as controls.
Methods

Animals
The studies were performed on 10 lean (Fa/Fa or Fa/fa) and 10 obese (fa/fa) age-matched 12-week-old male Zucker rats. Animals were born by using female (Fa/fa) and male (Fa/fa) breeders purchased from the Charles River Lab in France. One lean and one obese rat were obtained from the same breeder and were housed per cage. The ambient temperature was maintained at 251C and the animals were kept on an artificial 12-h light-dark cycle. The light period began at 0700 h. Rats were provided with standard laboratory chow (Lab Diet 5001; PMI Nutrition International Inc., Brentwood, MO, USA) and water ad libitum. All protocols were approved by the Institutional Animal Care and Use Committee of Chang Shan Medical University, Taichung, Taiwan.
Pulmonary ventilation
Breathing patterns were recorded using the barometric technique, of which complete details have previously been provided. 5, 6, 7 Briefly, a cylindrical plexiglas chamber with a volume of 4 l was used for the measurement of metabolic rate and breathing pattern. Gas flow through the chamber was provided from pressurized gas tanks. To measure ventilation, the chamber was completely sealed after momentarily interrupting the flow through it, and the pressure oscillations caused by breathing were recorded for less than 1 min by a sensitive pressure transducer (BIOPAC system, Inc., Goleta, CA, USA). The pressure signal was amplified by a preamplifier and displayed on the Biophysical Monitoring System (Model MP 100, BIOPAC). Injection and withdrawal of 0.3 ml of air with a 1-ml syringe was performed at least 12 times during the recording, for the purposes of calibration.
From the pressure oscillations due to breathing, tidal volume (V T ) was computed using the formula of Drorbaugh and Fenn, 20 incorporating the analytical modification suggested by Jacky. 21 For each condition, V T and breathing frequency (f) were calculated over a period corresponding to at least 30 successive breaths. Pulmonary ventilation ( . V E ) was also calculated (
.
, and was expressed at body temperature-atmospheric pressure-saturation (mlBTPS/kg/ min). Colonic temperature was measured continuously by a digital rectal thermoprobe, and taken as representative of body temperature (Tb).
Oxygen consumption and CO 2 production Oxygen consumption ( . VO 2 ) and CO 2 production ( . VCO 2 ) were measured from the inlet and outlet of the barometric chamber. The concentrations of O 2 and CO 2 entering and exiting the chamber were monitored with an O 2 gas analyzer (Model O 2 100C, BIOPAC) and an CO 2 analyzer (Model CO 2 100C, BIOPAC) arranged in series. The calibrations and linearities of the gas analyzers were checked twice daily, using certified calibration gases. Data were presented at standard temperature and pressure under dry conditions (STPD), corrected for the effective body mass exponent according to Refinetti, 22 and are expressed in kilograms to the power of 0.75 (mlO 2 STPD/kg 0.75 /min). Effective body mass (EBM) was calculated as 1.00 and 0.86M 0.75 for lean and obese Zucker rats, respectively (M: total body mass (kg)).
22
EBM was used to minimize the metabolic differences in adipose tissue mass between lean and obese rats.
Experimental protocol Animals were repeatedly tested at 3-day intervals following a subcutaneous injection of equal volumes of DMSO (vehicle: 1 ml/kg), or bicuculline methiodide (B M , 1 mg/kg, peripheral GABA A antagonist), or bicuculline hydrochloride (B HCl , 1 mg/kg, central and peripheral GABA A antagonist (Sigma Chemical, Co., St Louis, MO, USA). 5, 23, 24 The solutions of DMSO, B M , and B HCl were prepared daily and placed in vials labeled as solutions I, II, or III. The agents were given in a blinded, randomized design with 72 h elapsing between successive tests. All animals were divided into three groups and tests completed within a 9-day period from 0800 to 1720 h. The investigators involved in the testing were blinded to the contents of the vials and remained so until GABA and respiration in obesity T-B Lin et al both the ventilatory tests were completed and the data analyzed. In an attempt to minimize the stress level during the study, all animals were habituated to a restrainer with a rectal probe for 3 days a week for 1 month and to an experimental protocol inside the chamber for 2 days before the first study. To minimize any potential differences related to circadian rhythms, each rat was injected and tested at approximately the same time of the day. After the administration of the test agent and the insertion of the rectal thermoprobe, the rat was placed into the barometric chamber within the restrainer, and animals were exposed to room air for 30 min, hypoxic exposure (10% O 2 , balance N 2 ) for 30 min, and room air for 10 min. Ventilatory and metabolic data were collected at the 20th and 30th min post-drug administration during room air breathing, at the 35th, 40th, 50th, and 60th min post-drug administration during hypoxia, and at the 70th min post-drug administration during room air ( Figure 1 ).
Statistical analysis
Body weights of lean and obese rats were averaged over the 7-day experimental period and differences between the two groups were tested by unpaired Student t-test. The other parameters (
VCO 2 , and Tb) were analyzed by analysis of variance using the general linear model (GLM) in one between (lean and obese) and two within (gas exposures over time, drugs) design. Differences in ventilatory and metabolic parameters among vehicle, B M , and B HCl were subsequently tested as single group repeated measures with contrast transformation during room air and during hypoxic exposure in lean vs obese rats, separately. The contrast transformation is useful when one level of the repeated measures effect is a control level, DMSO, against which the other level, B M or B HCl , is compared. In all cases, a difference at Po0.05 was considered statistically significant. All data presented in the text, tables, and figures are means7s.e.m.
Results
Obese rats weighed about 40% more than age-matched lean animals (316716 vs 449724 g, Po0.01). Obese Zucker rats had a lower ventilation (
. V E , ml/min/kg) and a lower tidal volume (V T , ml/kg) than lean rats during room air breathing, and adopted a breathing strategy with a higher breathing frequency (f) ( Table 1) . There was a significant interaction in . V E between lean and obese rats (Po0.01). There was a significant interaction in . V E among three factors (phenotypes, time courses, and drugs) (Po0.01).
Room air
Ventilation during room air breathing measured at 20, 30, and 70 min post-drug administration was consistent under room air exposure. In lean Zucker rats, ventilation ( . V E ), tidal volume (V T ), breathing frequency (f), oxygen consumption ( . VO 2 ), carbon dioxide production ( . VCO 2 ), ventilatory equivalent for oxygen ( . V E / . VO 2 ), and ventilatory GABA and respiration in obesity Figure 2 ). Administration of B M had no effect on all parameters during room air breathing (f, V T ,
. Figure 2 ).
Acute hypoxia
In lean Zucker rats, all parameters (f, V T ,
VCO 2 , and Tb) were unaffected by the administration of either B M or B HCl during acute hypoxic exposure (Table 2 ). In contrast, during acute hypoxic exposure, obese Zucker treated with B HCl exhibited both a significant (Po0.05) elevation in V T and a decrease in f (5 min), which resulted in no change in . V E at 5 min hypoxic exposure (Table 2, Figure 2 ). At the same time, B HCl pretreatment did not alter other measured GABA and respiration in obesity T-B Lin et al parameters (
VCO 2 , Tb) in obese Zucker rats (Table 2) .
Sustained hypoxia
During sustained hypoxic exposure, lean rats injected with either B M or B HCl had no change in any of the measured parameters (f, V T ,
. VCO 2 , and Tb) ( Table 3) . Consistent with the findings during room air breathing and acute hypoxic exposure, administration of B M had no effect on any pulmonary parameters during sustained hypoxic exposure in obese Zucker rats (Table 3, Figure 2 ). In contrast, obese rats treated with B HCl , but not B M , exhibited significant elevations in V T ,
Discussion
Our findings can be summarized as follows: (1) endogenous GABA acting on GABA A receptors does not modulate ventilation during either room air breathing, acute hypoxic exposure, or sustained hypoxic exposure in lean Zucker rats; (2) endogenous GABA acting on peripheral GABA A receptors does not modulate ventilation during either room air breathing or hypoxic exposure in both lean and obese Zucker rats; (3) in obese rats, ventilation during room air breathing is depressed by endogenous GABAergic activity via GABA A receptors located within the CNS; (4) in obese rats, ventilation during acute hypoxia is not blunted by endogenous GABA acting on GABA A receptors, although the pattern of breathing in hypoxia is altered by central GABA A blockade; (5) during sustained hypoxic exposure, ventilation (via V T ) is persistently elevated via inhibition of central GABA A receptors in obese rats. Therefore, the data in this study provide additional support to our hypothesis that GABA and respiration in obesity T-B Lin et al endogenous GABA acting specifically on central, but not on peripheral, GABA A receptors modulates ventilation both during room air breathing and during sustained hypoxic exposure in obese, but not in lean Zucker rats. However, the ventilation in response to acute hypoxia is not regulated by endogenous GABA acting on GABA A receptors located within the CNS in obese Zucker rats, whereas endogenous GABA does modulate the pattern of breathing in a manner different from that occurring during sustained hypoxic exposure. GABA, a major inhibitory neurotransmitter in the mammalian CNS, can exert its effect via ionotropic GABA A receptors to produce fast synaptic inhibition. 24 GABA and other inhibitory neuromodulators have been demonstrated to have an important role in neural mechanisms of respiratory control. 12,13 GABA may be involved as a neurotransmitter in the modulation of respiratory-related neural activities, especially by acting on GABA A receptors. [25] [26] [27] In GABAergic neurons, GABA A receptors facilitate Cl À flux into neurons, resulting in hyperpolarization, whereas antagonism of GABA A receptors by bicuculline will decrease Cl À flux, resulting in depolarization and increased excitation. 13, 24 In the current experimental design, however, use of B M , a quaternary GABA A receptor antagonist that does not penetrate the blood-brain barrier (BBB) after systemic administration was used in conjunction with B HCl to distinguish peripheral from central actions of GABA acting on GABA A receptors. 23, 24 In the present study, B M and B HCl were injected systemically such that there would be widespread antagonistic actions. 24 Thus, it is difficult to localize any effect noted herein to any specific system or brain region. Our goal was rather to distinguish the relative importance of central vs peripheral GABAergic mechanisms in contributing to altered ventilatory response to acute and sustained hypoxic exposure in obese Zucker rats. Besides, due to a different GABAergic mechanism between normoxic and hypoxic ventilation, we had to make conclusion from observing the absolute values comparing bicuculline vs DMSO rather than from observing the change in ventilation comparing normoxia vs hypoxia. Further experiments using microinjections into specific brain regions will be required to identify those areas that are directly responsible for the ventilatory responses.
Ventilation during room air breathing B HCl significantly increased tidal volume (V T ) and minute ventilation ( . V E ) during room air breathing in obese, but not in age-matched lean, Zucker rats, whereas the observation was not found after the administration of B M , an agent that does not penetrate the BBB. The findings are consistent with our previous work after B HCl treatment during room air breathing. 5 28 showed that metabolic rate was independent of the central effects of GABA on respiration. Our results appear to support the concept that GABAergic modulation of ventilation is independent of metabolic rate or body temperature.
Ventilatory response to hypoxia
Lean Zucker rats exhibited an abrupt increase in ventilation in response to acute hypoxic exposure, followed by a gradual decline with sustained hypoxia. Obese Zucker rats, however, display a smaller initial increase in ventilation in response to hypoxia that plateaus as exposure to hypoxia continues. 6, 8, 9 The initial rise in ventilation in response to acute hypoxia originates from peripheral receptors, located mainly in the carotid body, which projects to the nucleus tractus solitarius (NTS) in the brain stem. 19 The gradual decline in ventilation as hypoxia continues noted in lean animals is thought to be mediated by central ventilatory depression in response to hypoxic depression of central neurons. 13 Lean rats treated with either B HCl or B M exhibited no alteration of ventilation ( . V E ) relative to vehicle (DMSO) during acute and sustained hypoxic responses, suggesting that endogenous GABA acting on GABA A receptors does not contribute to either the early or the late hypoxic ventilatory responses. Our current continued observation in lean Zucker rats is consistent with previous reports that B HCl fails to alter the ventilatory response to hypoxia in lean Zucker rats. 5 In contrast, obese rats treated with B HCl did exhibit significant elevations in tidal volume (V T ) but not in ventilation (
. V E ) and breathing frequency (f) during 5 min hypoxic exposure, therefore, suggesting ventilation ( . V E ) appeared not to be increased after B HCl administration due to an increase in V T and a decrease in f. During 10-30 min hypoxic exposure, obese rats treated with B HCl , but not B M , exhibited significant elevations in V T ,
. The ventilatory response to sustained hypoxia is regulated by endogenous GABA in obese Zucker rats in a different manner that occurring during acute hypoxic exposure. On the basis of the physiological measures, this is unlikely to be attributed to mechanical factors but to some feature of central respiratory control. This observation indicates that different mechanisms and/or neurointeractions may result in different effects on central respiratory neuron between early and late responses to hypoxia. Although multiple unknown factors may contribute to the different regulatory manner of hypoxic exposure, we can conclude that the altered pattern of the ventilatory response to hypoxia in obese Zucker rats is nevertheless clearly indicative of an important GABAergic role in this response. We conclude that the endogenous GABA that occurs naturally in obese Zucker rats acts exclusively on GABA A receptors located within the CNS to depress tidal volume during room air breathing and during acute and sustained hypoxic exposure and to depress ventilation during room air breathing and sustained hypoxic exposure. Except our study presenting altered GABAergic mechanism in obese Zucker rats due to a genetically induced defect of the leptin system, very limited information is related to the effect of leptin on GABA system. In addition to leptin, complex interactions among the various neurotransmitters and neuromodulators are also involved in the respiratory control of obesity, such as opioids, 7, 8 dopamine, 10 glutamate, 6 and nitric oxide 9 may directly or indirectly be involved in GABAergic regulation. Additional studies are required to address the complex neural mechanisms in morbidly obese humans. The precise underlying pathophysiology of OHS is unclear and involves multiple factors, including impaired respiratory control, respiratory muscle weakness, abnormal respiratory load compensation, and chest wall limitations. 1, 2, 29 The depressed chemical ventilatory drive is one recognized theory to explain the pathogenesis of OHS. 2, 29 Although a role of GABA in OHS has not to our knowledge been previously proposed, the current results suggest that GABAergic tonic inhibition within the CNS may be potentially responsible. Further clinical studies are required to clarify whether endogenous GABA within CNS plays an important role in the pathogenesis of OHS.
